Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
Fujifilm Toyama Chemical Co. Ltd. announced on 21 November an agreement with Canada’s Appili Therapeutics Inc. regardingrights to the antifungal T-2307 outside of Japan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?